GSK3β has been implicated in tau hyperphosphorylation, subsequent neurodegeneration [61], and silencing GSK3β leads to reduced plaque and tangle formation in transgenic mouse models of AD [62]. This evidence concerns the gene MAPT and Alzheimer disease.